In Apoe−/− mice, local delivery of IL-2 to atherosclerotic lesions [112] or treatment with IL-2/anti-IL-2 mAb immunocomplexes [113,114] lead to a reduction in atherosclerosis due to Treg expansion. The gene discussed is IL2; the disease is atherosclerosis.